Can neuroscience enlighten the philosophical debate about free will?

Compatibilism Conscious intention Decision-making Determinism Free choice Free will Libertarian Mental causation Physicalism

Journal

Neuropsychologia
ISSN: 1873-3514
Titre abrégé: Neuropsychologia
Pays: England
ID NLM: 0020713

Informations de publication

Date de publication:
09 09 2023
Historique:
received: 15 02 2023
revised: 24 06 2023
accepted: 26 06 2023
medline: 31 8 2023
pubmed: 30 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

Free will has been at the heart of philosophical and scientific discussions for many years. However, recent advances in neuroscience have been perceived as a threat to the commonsense notion of free will as they challenge two core requirements for actions to be free. The first is the notion of determinism and free will, i.e., decisions and actions must not be entirely determined by antecedent causes. The second is the notion of mental causation, i.e., our mental state must have causal effects in the physical world, in other words, actions are caused by conscious intention. We present the classical philosophical positions related to determinism and mental causation, and discuss how neuroscience could shed a new light on the philosophical debate based on recent experimental findings. Overall, we conclude that the current evidence is insufficient to undermine free will.

Identifiants

pubmed: 37385373
pii: S0028-3932(23)00166-5
doi: 10.1016/j.neuropsychologia.2023.108632
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108632

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Auteurs

Claire Delnatte (C)

Education nationale, académie de Paris, France.

Emmanuel Roze (E)

Sorbonne Université, Faculté de Médecine, INSERM U 1127, CNRS UMR 7225, Paris Brain Institute Institut du Cerveau, F-75013, Paris, France; Assistance Publique - Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, France.

Pierre Pouget (P)

Sorbonne Université, Faculté de Médecine, INSERM U 1127, CNRS UMR 7225, Paris Brain Institute Institut du Cerveau, F-75013, Paris, France.

Cécile Galléa (C)

Sorbonne Université, Faculté de Médecine, INSERM U 1127, CNRS UMR 7225, Paris Brain Institute Institut du Cerveau, F-75013, Paris, France.

Quentin Welniarz (Q)

Sorbonne Université, Faculté de Médecine, INSERM U 1127, CNRS UMR 7225, Paris Brain Institute Institut du Cerveau, F-75013, Paris, France. Electronic address: quentin.welniarz@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH